AGER and metabolic dysfunction-associated steatotic liver disease: Therefore, this study was designed to determine whether liraglutide could inhibit hepatocyte injury by inhibiting RAGE/NAPDH signal, and reduce the activation of hepatic stellate cells, thereby elucidating the action mechanism of liraglutide against NAFLD.